KEGG   PATHWAY: gas04650
Entry
gas04650                    Pathway                                
Name
Natural killer cell mediated cytotoxicity - Gracilinanus agilis (agile gracile opossum)
Description
Natural killer (NK) cells are lymphocytes of the innate immune system that are involved in early defenses against both allogeneic (nonself) cells and autologous cells undergoing various forms of stress, such as infection with viruses, bacteria, or parasites or malignant transformation. Although NK cells do not express classical antigen receptors of the immunoglobulin gene family, such as the antibodies produced by B cells or the T cell receptor expressed by T cells, they are equipped with various receptors whose engagement allows them to discriminate between target and nontarget cells. Activating receptors bind ligands on the target cell surface and trigger NK cell activation and target cell lysis. However Inhibitory receptors recognize MHC class I molecules (HLA) and inhibit killing by NK cells by overruling the actions of the activating receptors. This inhibitory signal is lost when the target cells do not express MHC class I and perhaps also in cells infected with virus, which might inhibit MHC class I exprssion or alter its conformation. The mechanism of NK cell killing is the same as that used by the cytotoxic T cells generated in an adaptive immune response; cytotoxic granules are released onto the surface of the bound target cell, and the effector proteins they contain penetrate the cell membrane and induce programmed cell death.
Class
Organismal Systems; Immune system
Pathway map
gas04650  Natural killer cell mediated cytotoxicity
gas04650

Other DBs
GO: 0042267
Organism
Gracilinanus agilis (agile gracile opossum) [GN:gas]
Gene
123230857  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]
123230879  LAT; LOW QUALITY PROTEIN: linker for activation of T-cells family member 1 [KO:K07362]
123231251  [KO:K05414]
123231252  [KO:K05414]
123231254  [KO:K05414]
123231336  SHC3; LOW QUALITY PROTEIN: SHC-transforming protein 3 [KO:K17448]
123231861  PRKCB; protein kinase C beta type isoform X1 [KO:K19662] [EC:2.7.11.13]
123232107  VAV1; proto-oncogene vav isoform X1 [KO:K05730]
123232290  [KO:K07360] [EC:2.7.10.2]
123232391  [KO:K02187] [EC:3.4.22.56]
123232515  [KO:K07828]
123232952  PPP3CB; serine/threonine-protein phosphatase 2B catalytic subunit beta isoform [KO:K04348] [EC:3.1.3.16]
123233359  PPP3R1; calcineurin subunit B type 1 [KO:K06268]
123233411  TNFRSF10A; tumor necrosis factor receptor superfamily member 10A [KO:K04722]
123233974  SOS2; son of sevenless homolog 2 [KO:K03099]
123233999  CD247; LOW QUALITY PROTEIN: T-cell surface glycoprotein CD3 zeta chain [KO:K06453]
123234105  SHC4; SHC-transforming protein 4 [KO:K17449]
123234292  RAC1; ras-related C3 botulinum toxin substrate 1 isoform X1 [KO:K04392]
123235914  [KO:K01353] [EC:3.4.21.79]
123236504  PRF1; perforin-1 [KO:K07818]
123236829  SOS1; son of sevenless homolog 1 isoform X1 [KO:K03099]
123236876  PIK3R1; phosphatidylinositol 3-kinase regulatory subunit alpha isoform X1 [KO:K02649]
123236954  PPP3CC; serine/threonine-protein phosphatase 2B catalytic subunit gamma isoform [KO:K04348] [EC:3.1.3.16]
123237042  PLCG2; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-2 [KO:K05859] [EC:3.1.4.11]
123237099  PTK2B; protein-tyrosine kinase 2-beta isoform X1 [KO:K05871] [EC:2.7.10.2]
123237139  NFATC2; nuclear factor of activated T-cells, cytoplasmic 2 [KO:K17332]
123237207  VAV2; guanine nucleotide exchange factor VAV2 isoform X1 [KO:K05730]
123237416  PLCG1; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 isoform X1 [KO:K01116] [EC:3.1.4.11]
123237498  LCP2; lymphocyte cytosolic protein 2 [KO:K07361]
123238040  MAP2K1; dual specificity mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]
123239466  RAF1; RAF proto-oncogene serine/threonine-protein kinase isoform X1 [KO:K04366] [EC:2.7.11.1]
123239917  NFATC1; nuclear factor of activated T-cells, cytoplasmic 1 [KO:K04446]
123240288  PIK3CD; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform [KO:K00922] [EC:2.7.1.153]
123240520  PAK1; serine/threonine-protein kinase PAK 1 isoform X1 [KO:K04409] [EC:2.7.11.1]
123242322  PIK3CB; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform isoform X1 [KO:K00922] [EC:2.7.1.153]
123242449  IFNAR2; interferon alpha/beta receptor 2 [KO:K05131]
123242450  IFNAR1; interferon alpha/beta receptor 1 [KO:K05130]
123242452  IFNGR2; interferon gamma receptor 2 [KO:K05133]
123242831  PIK3CA; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform [KO:K00922] [EC:2.7.1.153]
123243007  MAP2K2; dual specificity mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]
123243036  [KO:K07992]
123243037  HCST; hematopoietic cell signal transducer [KO:K07988]
123243044  [KO:K07293] [EC:3.1.3.48]
123243232  LCK; tyrosine-protein kinase Lck isoform X1 [KO:K05856] [EC:2.7.10.2]
123244440  SHC1; SHC-transforming protein 1 isoform X1 [KO:K06279]
123245100  TNF; tumor necrosis factor [KO:K03156]
123245333  PRKCA; protein kinase C alpha type isoform X1 [KO:K02677] [EC:2.7.11.13]
123245347  ICAM2; intercellular adhesion molecule 2 [KO:K06523]
123245523  GRB2; growth factor receptor-bound protein 2 [KO:K04364]
123245714  MAPK1; mitogen-activated protein kinase 1 isoform X1 [KO:K04371] [EC:2.7.11.24]
123245866  [KO:K06463]
123245896  FASLG; LOW QUALITY PROTEIN: tumor necrosis factor ligand superfamily member 6 [KO:K04389]
123246041  [KO:K06582]
123246567  FYN; tyrosine-protein kinase Fyn [KO:K05703] [EC:2.7.10.2]
123246700  VAV3; guanine nucleotide exchange factor VAV3 [KO:K05730]
123247043  FCER1G; high affinity immunoglobulin epsilon receptor subunit gamma [KO:K07983]
123247194  NRAS; GTPase NRas [KO:K07828]
123247403  SH2D1B; SH2 domain-containing protein 1B [KO:K07989]
123247605  RAC3; ras-related C3 botulinum toxin substrate 3 isoform X1 [KO:K07861]
123247645  ITGB2; integrin beta-2 [KO:K06464]
123247976  IFNGR1; interferon gamma receptor 1 [KO:K05132]
123248684  KRAS; GTPase KRas isoform X1 [KO:K07827]
123248687  BID; BH3-interacting domain death agonist [KO:K04726]
123249501  BRAF; serine/threonine-protein kinase B-raf isoform X1 [KO:K04365] [EC:2.7.11.1]
123249604  ITGAL; LOW QUALITY PROTEIN: integrin alpha-L [KO:K05718]
123250082  RAC2; ras-related C3 botulinum toxin substrate 2 [KO:K07860]
123250180  IFNG; interferon gamma [KO:K04687]
123250317  KLRK1; NKG2-D type II integral membrane protein [KO:K06728]
123250404  [KO:K05414]
123250411  [KO:K05414]
123250422  [KO:K05414]
123250431  [KO:K05415]
123250526  PTPN6; tyrosine-protein phosphatase non-receptor type 6 [KO:K05697] [EC:3.1.3.48]
123251014  SYK; tyrosine-protein kinase SYK [KO:K05855] [EC:2.7.10.2]
123251277  SH3BP2; SH3 domain-binding protein 2 [KO:K07984]
123251682  CASP3; caspase-3 [KO:K02187] [EC:3.4.22.56]
123251828  [KO:K07827]
123251883  [KO:K02187] [EC:3.4.22.56]
123252074  [KO:K02187] [EC:3.4.22.56]
123252235  PPP3CA; serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform [KO:K04348] [EC:3.1.3.16]
123252331  [KO:K05730]
123252332  [KO:K05730]
123253593  ARAF; serine/threonine-protein kinase A-Raf isoform X1 [KO:K08845] [EC:2.7.11.1]
123254168  [KO:K19663] [EC:2.7.11.13]
123255143  [KO:K19663] [EC:2.7.11.13]
123255551  [KO:K02187] [EC:3.4.22.56]
123256513  [KO:K02649]
123256515  [KO:K02649]
123256803  SHC2; SHC-transforming protein 2 [KO:K17447]
123256872  PTPN11; tyrosine-protein phosphatase non-receptor type 11 [KO:K07293] [EC:3.1.3.48]
Compound
C00076  Calcium cation
C00165  Diacylglycerol
C01245  D-myo-Inositol 1,4,5-trisphosphate
C05981  Phosphatidylinositol-3,4,5-trisphosphate
Reference
  Authors
Chiesa S, Tomasello E, Vivier E, Vely F.
  Title
Coordination of activating and inhibitory signals in natural killer cells.
  Journal
Mol Immunol 42:477-84 (2005)
DOI:10.1016/j.molimm.2004.07.030
Reference
  Authors
Maghazachi AA.
  Title
Insights into seven and single transmembrane-spanning domain receptors and their signaling pathways in human natural killer cells.
  Journal
Pharmacol Rev 57:339-57 (2005)
DOI:10.1124/pr.57.3.5
Reference
  Authors
Vivier E, Nunes JA, Vely F.
  Title
Natural killer cell signaling pathways.
  Journal
Science 306:1517-9 (2004)
DOI:10.1126/science.1103478
Reference
  Authors
Colucci F, Di Santo JP, Leibson PJ.
  Title
Natural killer cell activation in mice and men: different triggers for similar weapons?
  Journal
Nat Immunol 3:807-13 (2002)
DOI:10.1038/ni0902-807
Reference
  Authors
Perussia B.
  Title
Signaling for cytotoxicity.
  Journal
Nat Immunol 1:372-4 (2000)
DOI:10.1038/80808
Reference
  Authors
Smyth MJ, Cretney E, Kelly JM, Westwood JA, Street SE, Yagita H, Takeda K, van Dommelen SL, Degli-Esposti MA, Hayakawa Y.
  Title
Activation of NK cell cytotoxicity.
  Journal
Mol Immunol 42:501-10 (2005)
DOI:10.1016/j.molimm.2004.07.034
Reference
  Authors
Djeu JY, Jiang K, Wei S.
  Title
A view to a kill: signals triggering cytotoxicity.
  Journal
Clin Cancer Res 8:636-40 (2002)
Reference
  Authors
Smyth MJ, Takeda K, Hayakawa Y, Peschon JJ, van den Brink MR, Yagita H.
  Title
Nature's TRAIL--on a path to cancer immunotherapy.
  Journal
Immunity 18:1-6 (2003)
DOI:10.1016/S1074-7613(02)00502-2
Reference
  Authors
Colonna M.
  Title
Fine-tuning NK cell responses: it's a family affair.
  Journal
Nat Immunol 6:961-2 (2005)
DOI:10.1038/ni1005-961
Reference
PMID:8942070
  Authors
Bonnema JD, Leibson PJ.
  Title
Signal transduction during NK cell activation.
  Journal
Chem Immunol 64:28-43 (1996)
Reference
  Authors
Tassi I, Presti R, Kim S, Yokoyama WM, Gilfillan S, Colonna M.
  Title
Phospholipase C-gamma 2 is a critical signaling mediator for murine NK cell activating receptors.
  Journal
J Immunol 175:749-54 (2005)
DOI:10.4049/jimmunol.175.2.749
Reference
PMID:9143705
  Authors
Rao A, Luo C, Hogan PG.
  Title
Transcription factors of the NFAT family: regulation and function.
  Journal
Annu Rev Immunol 15:707-47 (1997)
DOI:10.1146/annurev.immunol.15.1.707
Reference
  Authors
Wu J, Lanier LL.
  Title
Natural killer cells and cancer.
  Journal
Adv Cancer Res 90:127-56 (2003)
DOI:10.1016/S0065-230X(03)90004-2
Reference
  Authors
Cerwenka A, Lanier LL.
  Title
Natural killer cells, viruses and cancer.
  Journal
Nat Rev Immunol 1:41-9 (2001)
DOI:10.1038/35095564
Reference
  Authors
Blott EJ, Griffiths GM.
  Title
Secretory lysosomes.
  Journal
Nat Rev Mol Cell Biol 3:122-31 (2002)
DOI:10.1038/nrm732
Reference
  Authors
Lieberman J.
  Title
The ABCs of granule-mediated cytotoxicity: new weapons in the arsenal.
  Journal
Nat Rev Immunol 3:361-70 (2003)
DOI:10.1038/nri1083
Reference
  Authors
Lord SJ, Rajotte RV, Korbutt GS, Bleackley RC.
  Title
Granzyme B: a natural born killer.
  Journal
Immunol Rev 193:31-8 (2003)
DOI:10.1034/j.1600-065X.2003.00044.x
Reference
  Authors
Liu D, Xu L, Yang F, Li D, Gong F, Xu T.
  Title
Rapid biogenesis and sensitization of secretory lysosomes in NK cells mediated by target-cell recognition.
  Journal
Proc Natl Acad Sci U S A 102:123-7 (2005)
DOI:10.1073/pnas.0405737102
Reference
PMID:9862693
  Authors
Trotta R, Puorro KA, Paroli M, Azzoni L, Abebe B, Eisenlohr LC, Perussia B.
  Title
Dependence of both spontaneous and antibody-dependent, granule exocytosis-mediated NK cell cytotoxicity on extracellular signal-regulated kinases.
  Journal
J Immunol 161:6648-56 (1998)
Reference
  Authors
Jevremovic D, Billadeau DD, Schoon RA, Dick CJ, Leibson PJ.
  Title
Regulation of NK cell-mediated cytotoxicity by the adaptor protein 3BP2.
  Journal
J Immunol 166:7219-28 (2001)
DOI:10.4049/jimmunol.166.12.7219
Related
pathway
gas04010  MAPK signaling pathway
gas04020  Calcium signaling pathway
gas04060  Cytokine-cytokine receptor interaction
gas04210  Apoptosis
gas04630  JAK-STAT signaling pathway
KO pathway
ko04650   

DBGET integrated database retrieval system